Fecal Continence Outcomes and Quality of Life After Excision of Sacrococcygeal Teratoma (Retrospective Study)
Launched by SOHAG UNIVERSITY · Nov 10, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how surgery for a type of tumor called sacrococcygeal teratoma affects children's bowel control and their overall quality of life. Sacrococcygeal teratoma is a tumor that can appear in newborns and may require surgery to remove it. While most of these tumors are not cancerous, they can still cause complications both before and after surgery. The study aims to gather information by asking parents to fill out a questionnaire about their child's ability to control bowel movements and how it impacts their daily life.
To participate in this study, children must be over three years old and have had surgery for sacrococcygeal teratoma after July 2010. However, children who have had certain complications or were lost to follow-up before six months after surgery will not be included. Parents can expect to provide valuable feedback that will help researchers understand the long-term effects of this surgery and guide future treatments for children with similar conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all patients with sacrococcygeal teratoma operated after july 2010 and older than 3 years old.
- Exclusion Criteria:
- • Patients lost to follow up before 6 months after surgery.
- • Patients with Currarino triad.
About Sohag University
Sohag University is a distinguished academic institution located in Sohag, Egypt, committed to advancing healthcare through rigorous clinical research. As a clinical trial sponsor, the university leverages its robust infrastructure and multidisciplinary expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a focus on ethical standards and scientific integrity, Sohag University collaborates with healthcare professionals and researchers to conduct trials that address critical health issues, ensuring the advancement of evidence-based practices in the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sohag, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported